What We're Reading: Page 198
Industry reads hand-picked by our editors
May 26, 2020
May 22, 2020
May 21, 2020
-
The Atlantic
We Live in a Patchwork Pandemic Now
-
STAT
The bizarre saga of a biotech frozen in time in the Covid-19 vaccine race
-
The Wall Street Journal
Europe Falls Behind U.S. in Funding Coronavirus Vaccine—and Securing Access
-
The New York Times
Trump's Vaccine Chief Has Vast Ties to Drug Industry, Posing Possible Conflicts
May 20, 2020
-
Forbes
The Man Betting $1 Billion That Pfizer Can Deliver A Vaccine By This Fall
-
BioCentury
Woodcock, Marks to recuse themselves from FDA reviews of COVID-19 products
-
Endpoints News
How a California biotech briefly tripled its value by hyping a Covid-19 ‘cure’
-
Bloomberg
Covid-19 Virus Mutation?: China's New Cluster Raises Concern
May 19, 2020
May 18, 2020
-
The New York Times
A Drug Company Wagers the U.S. Won’t Dare Charge It With Crimes
-
STAT
Utah embraced an unproven Covid-19 drug, then raced to course-correct
-
Reuters
GSK's long-acting injection beats Truvada in HIV prevention trial - Reuters
-
Axios
Why Deborah Birx is the real power doctor on the coronavirus task force
May 15, 2020
-
Bloomberg
Novartis CEO Says Covid-19 Vaccine May Take Until End of 2021
-
Kyodo News
Japan's health insurance to cover $1.5 million gene therapy drug
-
The Wall Street Journal
Why Big Investors Aren’t Betting It All on a Coronavirus Cure
-
STAT
FDA says Abbott’s 5-minute Covid-19 test may miss infected patients
Previous
